Persistent Corneal Epithelial Defect (PCED) research hub

Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)

This study looks at a new eye drop solution for people with persistent corneal epithelial defect (PCED), a long-lasting eye wound. It aims to see if the new drops can help the eye heal completely and safely within a few weeks.